Maryland General Assembly to Debate Price Regulation of Drugs
One of the major issues that will debated in the 2017 Maryland General Assembly Session will be a proposal regulating a number of aspects of pharmaceutical pricing. Proponents of the legislation, including major health care insurers, have said the legislation will include:

• Requiring “major” drug manufacturers to disclose the basis for prices of prescription drugs.
• Requiring “major” drug manufacturers to provide prior notice of increases on wholesale drug prices on any brand or specialty drug when the increase is 10 percent or more.
• Authorizing the Maryland Office of the Attorney General to take legal action to prevent price gouging by “major” drug corporations.

Earlier this year, Vermont passed legislation requiring pharmaceutical companies to justify price hikes on medicine.

If past this legislation would make Maryland the first state to authorize its Attorney General to investigate alleged price gouging and take pharmaceutical companies to court.